Dissolution difference between acidic and neutral media of acetaminophen tablets containing a super disintegrant and a soluble excipient. II

Chemical and Pharmaceutical Bulletin

Volumn 46, Issue 3, 1998, Pages 478-481

  Chen, Chun Ren ^a   Cho, Shu Ling ^b   Lin, Chih Kuang ^b   Lin, Yaw Hung ^b   Chiang, Shu Tuan ^b   Wu, Hsueh Line S ^c  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b Chen Ho Pharmaceutical Co Ltd   (Taiwan)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Ac Di Sol; Acetaminophen; Dissolution; PH; Primojel

Indexed keywords

ALLOPURINOL; CHLORPHENIRAMINE MALEATE; CROSCARMELLOSE SODIUM; EXCIPIENT; PARACETAMOL; STARCH GLYCOLATE SODIUM; SUCROSE; SURFACTANT;

ARTICLE; DISSOLUTION; DRUG SOLUBILITY; HYDROPHOBICITY; IONIC STRENGTH; PH; TABLET;

EID: 0031977650     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.46.478     Document Type: Article

References (13)

1. Chen C-R., Lin Y-H., Chow S-L., Yen S-Y., Wu H-L. S., Chem. Pharm. Bull., 45, 519-512 (1997).
2. Reference Tables/Description and Solubility, US Pharmacopoeia, 23th Ed., 1995. pp. 2071-2080.
3. Foye W. O., "Principles of Medicinal Chemistry," 3rd Ed., Lea & Febiger, Philadelphia, London, 1989, p. 863.
4. Dahl T. C., Sue I. T., Yum A., Drug Devel. Ind. Pharm., 17, 1001-1016 (1991).
5. Botzolakis J. E., Augsburger L. L., Drug Devel. Ind. Pharm., 14, 1235-1248 (1988).
6. Shangraw R., Mitrevej A., Shah M., Pharm. Tech., 4, 49-57 (1980).
7. Product Information of Primojel Ref. no.: 05.13.35.103 EF Avebe.
8. Bandelin F. J., "Pharmaceutical Dosage Forms: Tablets," Vol. 2, ed. by Lieberman H. A., Lachman L., Schwanz J. B., Marcel Dekker, Inc., New York, 1989. pp. 476-480.
9. Heng P. W. S., Wan L. S. C., Ang T. S. H., Drug Devel. Ind. Pharm., 16, 951-962 (1990).
10. Wan L. S. C., Heng P. W. S., Pharm. Acta Helv., 62, 169-174 (1987).
11. Wan L. S. C., Heng P. W. S., Pharm. Acta Helv., 61, 157-163 (1986).
12. Ganderton D., Pharm. Acta Helv., 42, 152-162 (1967).
13. Fatmi A. A., Hickson E. A., William G. V., Drug Devel. Ind. Pharm., 14, 711-719 (1988).